Login / Signup

Long-Term Efficacy and Safety of Adjunctive Perampanel in Patients From the Asia-Pacific Region With Refractory Focal-Onset Seizures in Study 335 Open-Label Extension.

Takuji NishidaSang Kun LeeYushi InoueKazunori SaekiKohei IshikawaManoj MalhotraAnna PattenSunao Kaneko
Published in: Epilepsia open (2023)
Overall, long-term seizure control was achieved with adjunctive perampanel in patients with refractory FOS, with or without FBTCS, in an Asia-Pacific population.
Keyphrases
  • end stage renal disease
  • open label
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • clinical trial
  • peritoneal dialysis
  • prognostic factors
  • squamous cell carcinoma
  • phase ii
  • study protocol